Correlation Between lodine-131 MIBG Imaging and Biological Markers in Advanced Neuroblastoma
- 1 January 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 13 (1) , 46-52
- https://doi.org/10.1097/00003072-198801000-00014
Abstract
I-131 metaiodobenzylguanidine (MIBG) imaging was performed in 38 patients with advanced neuroblastoma. Abnormal images were found in patients with elevations of urinary vanillylmandelic acid and dopamine and high serum neuron-specific enolase levels. Normal or minimal elevation of markers was seen in patients with negative images. In follow-up studies after chemotherapy, the disappearance of abnormal uptake was noted in those patients with normal marker values. A persistently abnormal uptake occurred in patients with high marker values. Conversion from a normal image to an abnormal image also occurred in patients whose markers became elevated. I-131 MIBG imaging is sensitive in detecting active foci of a neuroblastoma and is useful in monitoring chemotherapy in these patients.This publication has 8 references indexed in Scilit:
- SCANNING WITH I-131 METAIODOBENZYLGUANIDINE IN CHILDREN WITH SOLID TUMORS - AN INITIAL APPRAISAL1986
- Serum neuron‐specific enolase in children with neuroblastoma. Crelationship to stage and disease courseCancer, 1986
- I-131 METAIODOBENZYLGUANIDINE FOR THE LOCATING OF SUSPECTED PHEOCHROMOCYTOMA - EXPERIENCE IN 400 CASES1985
- I-131 METAIODOBENZYLGUANIDINE SCINTIGRAPHY FOR THE LOCATION OF NEURO-BLASTOMA - PRELIMINARY EXPERIENCE IN 10 CASES1985
- Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13AThe Journal of Pediatrics, 1984
- Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDPAmerican Journal of Roentgenology, 1983
- RADIOLABELED ADRENERGIC NEURON-BLOCKING AGENTS - ADRENOMEDULLARY IMAGING WITH [I-131]IODOBENZYLGUANIDINE1980
- Radionuclide Skeletal Survey in NeuroblastomaRadiology, 1979